Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Don’t forget to check out our premarket coverage here

• Fate Therapeutics, Inc. FATE fell 4.1% to $6.13 in pre-market trading. Fate Therapeutics is expected to report Q4 results on Tuesday, Feb. 28, 2023.
• Cleveland-Cliffs Inc. CLF dropped 3.8% to $19.35 in pre-market trading. For the fourth quarter, the company recorded a net loss of $204 million, corresponding to a loss of $0.41 per diluted share as against a net income of $899 million, or $1.69 per diluted share in the same period of the previous quarter.
• Vir Biotechnology, Inc. VIR fell 3.4% to $25.30 in pre-market trading. Vir Biotechnology reported amended collaboration agreement with GSK.

Now Read This: Coca-Cola All Set To Report Earnings Today; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts